Integrin and neurocan binding to L1 involves distinct Ig domains.
about
Neurocan is dispensable for brain developmentCell Adhesion Molecules and Ubiquitination-Functions and SignificanceComposition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycansInhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseasesL1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma.Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding.L1CAM in human cancer.Plasmin-sensitive dibasic sequences in the third fibronectin-like domain of L1-cell adhesion molecule (CAM) facilitate homomultimerization and concomitant integrin recruitmentEctodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins.Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.Role of L1CAM for axon sprouting and branching.L1CAM: a major driver for tumor cell invasion and motility.Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules.A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells.L1 (CD171) is highly expressed in gastrointestinal stromal tumors.The third fibronectin type III repeat is required for L1 to serve as an optimal substratum for neurite extension.Neuroadhesive L1 coating attenuates acute microglial attachment to neural electrodes as revealed by live two-photon microscopy.Pharmacology of cell adhesion molecules of the nervous system.L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.L1 (CD171) as a novel biomarker for ovarian and endometrial carcinomas.Expression and immunohistochemical localization of heparan sulphate proteoglycan N-syndecan in the migratory pathway from the rat olfactory placode.Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation.
P2860
Q24550861-1C6C9214-38F6-427D-8B80-11FE8C641D2EQ26771983-B755F638-C682-4784-B58C-003D76995BDBQ28576541-CBF857B8-0157-40ED-8DFA-48845F4F8119Q28647140-87FB995E-FBD9-4180-A251-E773738A55F1Q33829964-46C9D82C-CE02-4C82-95B1-5D6994326F3FQ33912948-576C2080-A87E-478F-9A84-EE6F3821BD70Q34482366-C85292A4-6118-4831-BD6F-D35770C7A3D8Q36328335-093E3514-1E34-45DD-B9DE-566EF21CFCE0Q36380055-A11DA778-6344-4705-9907-7D8FF4AF9970Q37419486-594039B5-867D-48F9-B048-4E9C223FC3B5Q37457845-D3595D62-465C-4EF3-A07A-DD012C1BA15AQ37988734-F76E7468-ECDD-439D-93FE-0F1DF922927AQ38026420-B4A4B01B-FDEA-4316-A4BC-47880A69D67DQ38517679-1E2DC228-03A1-47D1-BA83-BF07CF761ED4Q38745563-BCAD90F8-B540-4FA1-B3A7-E762C9FC8996Q39415443-D94AF62A-1DBD-4637-AE05-9095C3699986Q39986415-92E9BE6A-18FC-4ECD-84AF-4AF183F81BD1Q40359512-F1ED1D62-0094-42BF-A3F0-A92FAB77BE53Q40872566-0D1EC0B9-E51B-4535-85C0-ABC7F968EFC6Q41463253-B4A1B573-D973-4E82-B107-D9AF068F14BDQ41963297-B69A5C08-525D-42BB-AD81-55E5FB860C13Q45959051-1BAAF7ED-F153-49A0-A251-3D6152F0FC2EQ47270209-CCFE077E-DE91-451C-A5DC-88AC0EC86051Q48597600-9075CDD6-5C84-43BF-AF11-218533B13657Q52144637-D9F2136F-D10F-4E1A-BF4D-2E4939D28E19
P2860
Integrin and neurocan binding to L1 involves distinct Ig domains.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Integrin and neurocan binding to L1 involves distinct Ig domains.
@en
Integrin and neurocan binding to L1 involves distinct Ig domains.
@nl
type
label
Integrin and neurocan binding to L1 involves distinct Ig domains.
@en
Integrin and neurocan binding to L1 involves distinct Ig domains.
@nl
prefLabel
Integrin and neurocan binding to L1 involves distinct Ig domains.
@en
Integrin and neurocan binding to L1 involves distinct Ig domains.
@nl
P2093
P2860
P356
P1476
Integrin and neurocan binding to L1 involves distinct Ig domains.
@en
P2093
M Oleszewski
P Altevogt
P2860
P304
24602-24610
P356
10.1074/JBC.274.35.24602
P407
P577
1999-08-01T00:00:00Z